Global Polymer-based Prefilled Syringe Market By Type (COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer) and Other), By Application (Antithrombotics, Vaccines, Biologics and Other) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

The market for polymer-based prefilled syringes is taken into consideration due to the necessity for convenience, fewer errors in clinical medicine, and awareness of required dose. The demand for high-quality, dependable packaging is growing as more sensitive medications hit the market. The prefilled syringe made of polymer is cost-effective, safe, and provides a precise dose while maintaining a high quality standard. Polymer-based prefilled syringes are more flexible, have greater tolerance power, are break resistant, and come in appealing forms. They have exceptional transparency and are impact resistant. Prefilled syringes made of polymers have a consistent gliding force, a lesser risk of drug degradation, and better material strength and barrier qualities. Polymer-based prefilled syringes are essential in a variety of therapies because they are sterile and contamination-free. Because the prefilled syringe is made of polymer, it is chemically inert, reducing the risk of chemical interactions with sensitive medications. This element can help prevent drugs from losing their potency and consumers from overfilling their prescriptions. Therapy is self-administered in developing countries, necessitating the development of new installation solutions that meet the needs of the customers. The prefilled syringe made of polymer is effective in delivering the essential medicament. The Global Polymer-based Prefilled Syringe Market accounted for US$ 6911.69 million in 2020 and is estimated to be US$ 32913.6 million by 2030 and is anticipated to register a CAGR of 10.40%.

Ability to provide reliable and predictable medication performance boost the market growth

The market for polymer-based prefilled syringes is predicted to grow due to its ability to provide reliable and predictable medication performance. To treat chronic diseases, there was a need for a shift in treatment from hospitals to home care. The expansion of the polymer-based prefilled syringe market has been propelled by the shift in patient care brought about by the advancement of biopharmaceutical medicinal products. When mistreated, glass prefilled syringes can shatter, allowing heavy metals to leak out, fueling the expansion of the polymer-based prefilled syringe market. Despite the fact that polymer-based prefilled syringes have had a significant impact on the healthcare industry, there are some constraints that may limit the market's growth.

They have a higher gas permeability than glass prefilled syringes, which can let atmospheric air into the syringe, making glass prefilled syringe an excellent barrier. Because of the requirement for enhanced health issues, glass is regarded to be more dominating than polymer. Despite the fact that glass prefilled syringes have more advantages than polymer-based prefilled syringes, the polymer-based prefilled syringe market is predicted to develop due to its convenience of use and low cost. In comparison to the polymer-based prefilled syringe industry, the glass prefilled syringe market is expected to grow slowly. This market's net sales could be boosted by innovation in a polymer-based prefilled syringe that provides superior moisture-barrier.

The Global Polymer-based Prefilled Syringe Market is segmented based on type, application, and region.

On the basis of Type, the Global Polymer-based Prefilled Syringe Market is segmented into COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer) and other. Based on Application, the target market is segmented into Antithrombotics, Vaccines, Biologics and Other.

Regional Insights:

On region the Global Polymer-based Prefilled Syringe Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Countries in Europe, North America, and Asia Pacific have the highest drug consumption and a large pharmaceutical market, thus demand for polymer-based prefilled syringes is likely to grow. The market for polymer-based prefilled syringes in developed nations such as the United States, Italy, and the United Kingdom is predicted to increase at a healthy rate during the forecast period. It was ascribed to the strong demand for polymer-based prefilled syringes used in pharmaceutical packaging. The market for polymer-based prefilled syringes in developing nations such as India, China, and others is predicted to grow in response to rising demand to reduce medical errors and boost convenience.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Polymer-based Prefilled Syringe Market report based on Type, Application, and region.

Global Polymer-based Prefilled Syringe Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The prominent players operating in the Global Polymer-based Prefilled Syringe Market includes Ajinomoto Bio-Pharma, Inc., Aptar Pharma (India) Pvt. Ltd., Baxter International Inc., Biocorp, Enable Injections, Inc., Nipro Corp., SHL Medical, Shandong Weigao Group, Stevanato Group and Unilife Corporation.

• Ajinomoto Bio-Pharma, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Aptar Pharma (India) Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Baxter International Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Biocorp
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Enable Injections, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Nipro Corp.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• SHL Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Shandong Weigao Group
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies